在炎症性肠病患者中使用大麻与更长的内镜持续时间和内镜炎症有关
Lauren Loeb1, Alexander Hochwald2, Michael F Picco1
1Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Crohn's & colitis 360
|July 16, 2025
概括
使用大麻的炎症性肠病 (IBD) 患者经历了更长的内镜手术,并显示出更多的炎症. 这凸显了需要更好的药物调和和进一步研究大麻的需要.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠道疾病 (IBD) 管理通常涉及替代疗法,如大麻由于治疗耐药性.
- 在IBD患者中,大麻的使用显示出其抗炎作用的混合结果.
- 以前的研究表明,大麻使用者可能需要增加医疗程序的镇静剂.
研究的目的:
- 调查报告使用大麻的IBD患者是否需要更多的资源进行内镜手术.
- 为了确定在IBD患者中使用大麻是否与增加的内镜炎症有关.
- 为了比较IBD患者与未报告使用大麻的患者之间的资源利用和炎症标志物.
主要方法:
- 追溯病例控制研究设计.
- 包括成人IBD患者进行内镜评估,以检查急性IBD相关的投诉.
- 根据年龄,性别和BMI,将病例 (大麻使用者) 与对照 (非使用者) 相匹配.
主要成果:
- 与非使用者 (n=62) 相比,大麻使用者 (n=62) 的内镜持续时间明显更长.
- 报告使用大麻的IBD患者更有可能出现内镜炎症 (P=.044).
- 在康复室停留,IBD治疗,狭窄的存在,或调整的propofol剂量没有发现显著差异.
结论:
- 使用大麻的IBD患者的内镜手术时间更长,内镜炎症率更高.
- 研究结果强调了药物调和对于IBD护理中准确的资源配置的重要性.
- 进一步的研究,包括随机对照试验,对于了解大麻对IBD患者结果的影响至关重要.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
204
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
204
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
01:30Inflammatory Bowel Disease II: Crohn's Disease
392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
272
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
272
01:29Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
332
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
332